The costs of managing severe cancer pain and potential savings from transdermal administration
- 31 December 1994
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 30 (4), 463-468
- https://doi.org/10.1016/0959-8049(94)90420-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A pilot study, review of the literature, and dosing guidelines for patient-controlled analgesia using subcutaneous morphine sulphate for chronic cancer painPalliative Medicine, 1992
- Drug management of pain caused by cancer: a study of general practitioners' treatment attitudes and practicesPalliative Medicine, 1992
- Review articles : Transdermal and inhalatory routes of opioid administration: the potential application in cancer painPalliative Medicine, 1992
- A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at homeJournal of Clinical Epidemiology, 1991
- Review article : Opioid analgesics in the management of pain in patients with cancer: an updatePalliative Medicine, 1991
- Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer painThe Lancet, 1991
- The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systemsPain, 1990
- Transdermal fentanyl for pain control in patients with cancerPain, 1989
- A new approach to the administration of opiates: TTS (fentanyl) in the management of pain in patients with cancerJournal of Pain and Symptom Management, 1988
- Safety and efficacy of continuous intravenous morphine for severe cancer painAmerican Journal Of Medicine, 1984